Elinor Langfelder-Schwind

Ms. Elinor Langfelder-Schwind

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
PFPhilip Farrell
Philip Farrell
ELElinor Langfelder-Schwind
Elinor Langfelder-Schwind
MFMichael H. Farrell
Michael H. Farrell

29 December 2021 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
ELElinor Langfelder-Schwind
Elinor Langfelder-Schwind
KRKaren Siklosi Raraigh
Karen Siklosi Raraigh
TWThe Cf Newborn Screening Genetic Counseling Workgroup
The Cf Newborn Screening Genetic Counseling Workgroup
RPRichard Parad
Richard Parad

1 March 2020 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
LDLara Dhingra
Lara Dhingra
PWPatricia Walker
Patricia Walker
MBMaria Berdella
Maria Berdella
APAmy Plachta
Amy Plachta
JCJack Chen
Jack Chen
RPRussell K. Portenoy
Russell K. Portenoy

24 September 2019 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
ELElinor Langfelder-Schwind
Elinor Langfelder-Schwind
KRKaren Siklosi Raraigh
Karen Siklosi Raraigh
RPRichard Parad
Richard Parad

1 January 2016 in Journal of Cystic Fibrosis
Verified
Journal Article
Open access
PDF file
JBJulie Balzano
Julie Balzano
AFAshley Fresenius
Ashley Fresenius
PWPatricia Walker
Patricia Walker
MBMaria Berdella
Maria Berdella
RPRussell K. Portenoy
Russell K. Portenoy
LDLara Dhingra
Lara Dhingra
Cystic fibrosis (CF) causes high illness burden. Screening may identify patients who could potentially benefit from interventions for symptoms or other sources of distress. We evaluated the feasibility of a web-based system for routine monitoring. Adult CF patients enrolled in a study of palliative care service delivery completed web-based assessments every 30 days on global distress, physical and psychological symptom distress, and the perceived benefits of discussing advance care planning (ACP) with CF clinicians. Feasibility was assessed by the rate of survey completion, survey reminders, and missed surveys during a 9-month rolling enrollment period. Of 74 participants (47.3% women, 94.4% white), 36.7% had comorbid diabetes, and 56.9% had an FEV1% predicted score of 40-69. In total, patients completed 456 (80.6%) of 566 surveys every 30 days over the assessment period. Sixty-five (87.8%) completed 405 (79.7%) of 508 surveys online and 9 (12.2%) completed 51 (88.0%) of 58 surveys using a combination of online, telephone, and mail-based methods. Many surveys were completed without reminders (online: 261 [64.4%] of 405; combined methods: 29 [56.9%] of 51), with 166 (36.4%) surveys requiring 1 or more reminders. Further, 23.0% (17) of patients noted elevated global distress; 20.3% (15) endorsed physical symptom distress, 12.2% (9) had psychological distress, and 58.1% (43) reported that discussing ACP would be beneficial. Repeated web-based screening for symptom distress and ACP preferences is feasible in adult CF patients. Future studies should assess the system's generalizability and staff resources when implementing reminders and non-web methods of completion.

12 July 2023 in Life
Verified
Journal Article
Open access
PDF file
JMJulie McGlynn
Julie McGlynn
JDJoan Kathleen DeCelie-Germana
Joan Kathleen DeCelie-Germana
CKCatherine Kier
Catherine Kier
ELElinor Langfelder-Schwind
Elinor Langfelder-Schwind
With the advent of highly effective modulator therapies, many people with cystic fibrosis (CF) are living longer, healthier lives. Pregnancy rates for women with CF more than doubled between 2019 and 2021, reflecting increases in both planned and unplanned pregnancies. For men with CF, CF-associated infertility can be mitigated with assistive reproductive technology, yet patient knowledge of these challenges and options is variable. Preconception and prenatal counseling for individuals with CF and for parents of children with CF who wish to expand their families requires nuanced discussions to promote informed reproductive decisions, drawing from a combination of standard practice recommendations and CF-specific assessments. This review article synthesizes the current literature and practice recommendations regarding reproductive counseling and care in CF, outlining the role of genetic counseling, carrier screening, teratogen counseling, in vitro fertilization and pre-implantation genetic diagnosis, and careful assessment and management of cystic fibrosis-related diabetes when present. Via a multidisciplinary, patient-centered approach, clinicians can support adults with CF and parents of children with CF as they make informed reproductive decisions and embark on family planning.